Towards a Neurodevelopmental Model of Clinical Case Formulation

Psychiatric Clinics of North America

Volumn 32, Issue 1, 2009, Pages 199-211

  Solomon, Marjorie ^a,b   Hessl, David ^a,b   Chiu, Sufen ^b   Olsen, Emily ^a   Hendren, Robert L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Case formulation; Endophenotypes; Fragile X Syndrome; Neurodevelopment; Pervasive developmental disorder

Indexed keywords

AUTISM; CASE REPORT; CHILD; CLINICAL PRACTICE; DISEASE MODEL; DOWN SYNDROME; FEMALE; FRAGILE X SYNDROME; GENETIC COUNSELING; HUMAN; MENTAL DISEASE; MOLECULAR GENETICS; NEUROBIOLOGY; NEURODEVELOPMENTAL MODEL; NEUROIMAGING; PHENOTYPE; PRIORITY JOURNAL; RETT SYNDROME; REVIEW;

ANXIETY DISORDERS; BRAIN; CHILD; CHILD BEHAVIOR DISORDERS; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FRAGILE X SYNDROME; HUMANS; MODELS, NEUROLOGICAL; NERVOUS SYSTEM;

EID: 60549106679     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2008.11.003     Document Type: Review

References (63)

1. Jensen P.S. Developmental psychopathology courts developmental neurobiology: current issues and future challenges. Semin Clin Neuropsychiatry 3 (1998) 333-337
2. Skuse D.H. Behavioural neuroscience and child psychopathology: insights from model systems. J Child Psychol Psychiatry 41 (2000) 3-31
3. Hagerman R.J. Neurodevelopmental disorders: diagnosis and treatment (1999), Oxford University Press, New York
4. In: Eells T.D. (Ed). Psychotherapy Case Formulation (1997), The Guilford Press, New York
5. Pennington B.F. The development of psychopathology (2002), Guilford, New York
6. Cannon T.D., and Rosso I.M. Levels of analysis in etiological research on schizophrenia. Dev Psychopathol 14 (2002) 653-666
7. Tandon R., Keshavan M.S., and Nasrallah H.A. Schizophrenia, "just the facts," what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 102 (2008) 1-18
8. Solomon M., Hessl D., Chiu S., et al. A genetic etiology of pervasive developmental disorder guides treatment. Am J Psychiatry 164 4 (2007) 575-580
9. Tassone F., Hagerman R.J., Ikle D.N., et al. FMRP expression as a potential prognostic indicator in Fragile X Syndrome. Am J Med Genet 84 3 (1999) 250-261
10. Reiss A.L., and Freund L. Behavioral phenotype of Fragile X Syndrome: DSM-III-R autistic behavior in male children. Am J Med Genet 43 (1992) 35-46
11. Bregman J.D., Leckman J.F., and Ort S.I. Fragile X Syndrome: genetic predisposition to psychopathology. J Autism Dev Disord 18 (1988) 343-354
12. Cohen I.L., Fisch G.S., Sudhalter V., et al. Social gaze, social avoidance, and repetitive behavior in fragile X males: a controlled study. Am J Ment Retard 92 5 (1988) 436-446
13. Cohen I.L., Brown W.T., Jenkins E.C., et al. Fragile X syndrome in females with autism. Am J Med Genet 34 2 (1989) 302-303
14. Cohen I.L., Sudhalter V., Pfadt A., et al. Why are autism and the Fragile-X Syndrome associated? Conceptual and methodological issues. Am J Hum Genet 48 2 (1991) 195-202
15. Hagerman R.J., Amiri K., and Cronister A. Fragile X checklist. Am J Med Genet 38 (1991) 283-287
16. Hessl D., Dyer-Friedman J., Glaser B., et al. The influence of environmental and genetic factors on behavior problems and autistic symptoms in boys and girls with Fragile X Syndrome. Pediatrics 108 5 (2001 Nov) E88
17. Bailey Jr. D.B., Mesibov G.B., Hatton D.D., et al. Autistic behavior in young boys with Fragile X Syndrome. J Autism Dev Disord 28 6 (1998) 499-508
18. Hagerman R.J., Jackson III A.W., Levitas A., et al. An analysis of autism in fifty males with the Fragile X Syndrome. Am J Med Genet 23 1-2 (1986) 359-374
19. Rogers S.J., Wehner D.E., and Hagerman R. The behavioral phenotype in fragile X: symptoms of autism in very young children with Fragile X Syndrome, idiopathic autism, and other developmental disorders. J Dev Behav Pediatr 22 (2001) 409-417
20. Sudhalter V., Cohen I.L., and Silverman W. Wolf-Schein EG: conversational analyses of males with Fragile X, Down syndrome, and autism: comparison of the emergence of deviant language. Am J Ment Retard 94 4 (1990) 431-441
21. Rivera S.M., Menon V., White C.D., et al. Functional brain activation during arithmetic processing in females with Fragile X Syndrome is related to FMR1 protein expression. Hum Brain Mapp 16 4 (2002) 206-218
22. Rivera S.M., Reiss A.L., Eckert M.A., et al. Developmental changes in mental arithmetic: evidence for increased functional specialization in the left inferior parietal cortex. Cereb Cortex 15 11 (2005) 1779-1790
23. Hessl D., Tassone F., Cordeiro L., et al. Aggression and stereotypic behavior in males with Fragile X Syndrome: moderating secondary genes in a "single gene" disorder. J Autism Dev Disord 38 1 (2008) 184-189
24. Hariri A.R., Mattay V.S., Tessitore A., et al. Dextroamphetamine modulates the respone of the human amygdala. Neuropsychopharmacology 27 6 (2002) 1035-1040
25. Brune C.W., Kim S.J., Salt J., et al. 5-HTTLPR Genotype-specific phenotype in children and adolescents with autism. Am J Psychiatry 163 12 (2006) 2148-2156
26. Manuck S.B., Flory J.D., Ferrel R.E., et al. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res 95 1 (2000) 9-23
27. Swann A.C. Neuroreceptor mechanisms of aggression and its treatment. J Clin Psychiatry 64 (2003) 26-35
28. Cohen I.L., Liu X., Schutz C., et al. Association of autism severity with a monoamine oxidase A functional polymorphism. Clin Genet 63 3 (2003) 190-197
29. Lawson D.C., Turic D., Langley K., et al. Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 116 1 (2003) 84-89
30. Jonsson E.G., Norton N., Forslund K., et al. Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. Schizophr Res 61 (2003) 31-37
31. Greenough W.T., Klintsova A.Y., Irwin S.A., et al. Synaptic regulation of protein synthesis and the fragile X protein. Proc Natl Acad Sci USA 98 13 (2001) 7101-7106
32. Freund L.S., and Reiss A.L. Cognitive profiles associated with the fra (X) syndrome in males and females. Am J Med Genet 38 (1991) 542-547
33. Cornish K., Munir F., and Wilding J. A neuropsychological and behavioural profile of attention deficits in fragile X syndrome. Rev Neurol 33 (2001) S24-S29
34. Kaufman A.S., and Kaufman N.L. Kaufman Assessment Battery for Children (1983), American Guidance Services, Circle Pines (MN)
35. Woodcock R.W., and Mather N. Woodcock-Johnson III Tests of Achievement (2001), Riverside Publishing, Itasca (IL)
36. Lord C., Risi S., and Lambrecht L. The autism diagnostic observation schedule generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30 (2000) 205-223
37. Berument S.K., Rutter M., Lord C., et al. Autism screening questionnaire: diagnostic validity. Br J Psychiatry 175 (1999) 444-451
38. Rourke B.P. Nonverbal learning disabilities: syndrome and the model (1989), Guilford, New York
39. Rothbart M., and Bates J. Temperament, in Handbook of Child Psychology (1998), John Wiley & Sons, Inc., New York p.105-76
40. Bhangoo R.K., and Leibenluft E. Affective neuroscience and the study of normal and abnormal emotion regulation. Child Adolesc Psychiatr Clin N Am 11 (2002) 519-532
41. Jacquemont S., Hagerman R., Leehey J., et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet 72 (2003) 869-878
42. Yang S.Z., Dong J.H., Li K., et al. Detection of AFPmRNA and melanoma antigen gene-1mRNA as markers of disseminated hepatocellular carcinoma cells in blood. Hepatobiliary Pancreat Dis Int 4 2 (2005) 227-233
43. Yang S.Z., Dong J.H., Zhu K., et al. Detection of alpha-fetoproteins mRNA and melanoma agen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance. Zhonghua Wai Ke Za Zhi 42 17 (2004) 1060-1063
44. Sharp F. Gene expression profiles for children with and without symptoms of regression in autism (March 2005), M.I.N.D. Institute Research Meeting, Sacramento, CA, Davis (CA)
45. Gottesman I.I., and Gould T.D. The endophenotype concept in psychiatry; etymology and strategic intentions. Am J Psychiatry 160 (2003) 636-645
46. Gottesman I., and Shields J. Schizophrenia and Genetics: a twin study vantage point (1972), Academic Press, New York
47. Heiser P., Friedel S., Dempfle A., et al. Molecular genetic aspects of attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev 28 6 (2004) 625-641
48. Nigg J.T., Blaskey L.G., Stawicki J.A., et al. Evaluating the endophenotype model of ADHD combined and inattentive subtypes. J Abnorm Psychol 113 (2004) 614-625
49. Dawson G., Webb S., Schellenberg G.D., et al. Defining the broader phenotype of autism: genetic, brain, and behavioral perspectives. Dev Psychopathol 14 (2002) 581-611
50. Leibenluft E., Charney D.S., Towbin K.E., et al. Defining clinical phenotypes of juvenile mania. Am J Psychiatry 160 (2003) 430-437
51. Gogtay N., Giedd J.N., Lusk L., et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA 101 21 (2004) 8174-8179
52. Schumann C.M., Hamstra J., Goodlin-Jones B.L., et al. The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. J Neurosci 24 (2004) 6392-6401
53. Durston S., Fossella J.A., Casey B.J., et al. Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol Psychiatry 10 (2005) 678-685
54. Vaidya C.J., Austin G., Kirkorian G., et al. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci USA 95 (1998) 14494-14499
55. Lewis D.A., Volk D.W., and Hashimoto T. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology (Berl) 174 (2004) 143-150
56. Barch D.M., Mitropoulon V., Harvey P.D., et al. Context-processing deficits in schizotypal personality disorder. J Abnorm Psychol 113 4 (2004) 556-568
57. Dölen G., and Bear M.F. Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of Fragile X Syndrome. J Physiol 586 6 (2008) 1503-1508 Epub 2008
58. Temple E., Deutsch G.K., Poldrack R.A., et al. Neural deficits in children with dyslexia ameliorated by behavioral remediation: evidence from functional MRI. Proc Natl Acad Sci USA 100 (2003) 2860-2865
59. Rueda M.R. Training children's executive attention (2005), UC Davis M.I.N.D. Institute, Sacramento (CA)
60. Rueda M.R., Rothbart M.K., McCandliss B.D., et al. Training, maturation, and genetic influences on the development of executive attention. Proc Natl Acad Sci USA 102 41 (2005) 14931-14936
61. J. Tanaka C. Klaiman K. Koenig Plasticity of the neural mechanisms underlying face processing in children with ASD: behavioral improvements following perceptual training with faces. International Meeting for Autism Research, Boston, MA: May 2005.
62. Hogarty G.E., Flesher S., Ulrich R., et al. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Arch Gen Psychiatry 61 (2004) 866-876
63. Erikson K., Gabry K.E., Schulkin J., et al. Social withdrawal behaviors in nonhuman primates and changes in neuroendocrine and monoamine concentrations during a separation paradigm. Dev Psychobiol 46 (2005) 331-333